Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

MRCPsych Part B > Adult Psychiatry 1 > Flashcards

Adult Psychiatry 1 Flashcards

1
Q

Point prevalence estimate of depression?

A

7%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Which age group is at highest risk for depression?

A

> 30

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Mean age of onset of depression?

A

30

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

When does first depressive episode occur for 50% of patients?

A

<40

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Mean number of episodes of depression in patients with lifetime depression?

A

5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Longest duration of depression?

A

24 weeks per episode

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How many depressed patients receive antidepressants in a year?

A

21%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How many patients have consulted their GP in a year about their depression?

A

One third

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How many patients with depression have seen a psychiatrist in one year?

A

21%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How many patients with depression remain untreated despite seeking help?

A

21%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Mean age of treatment onset for depression?

A

33.5 years - lag 3 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Most common comorbidity with depression?

A

Alcohol use (>40%)
Anxiety (>40%)
PD (30%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Which PD has a strong association with lifetime depression?

A

Cluster C except for anankastic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How many people with depression attempt suicide?

A

9%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How many patients with depression fail to seek treatment?

A

43%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How many times do patients with depression see their GP compared to non-sufferers?

A

Three times as many

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How many patients with depression who seek help are given antidepressants?

A

31%
25% of these are antidepressants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

In how many patients does the initial diagnosis of depression change?

A

56%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What does the initial diagnosis of depression change to in patients?

A

Schizophrenic spectrum - 16%
PD - 9%
Neurotic, stress-related and somatoform disorders - 8%
Bipolar - 8%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Who did studies into the changes in diagnosis of patients initially diagnosed with depression?

A

Kessing, 2005

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

In the community, how many patients with a depressive episode go on to develop mania?

A

One in ten patients within ten years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

How many severely depressed patients in hospital go on to develop an episode of mania?

A

50%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Which types of patients with bipolar typically begin with a depressive episode?

A

Females

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What factors are associated with a change from depression to mania?

A

Young age
FH of bipolar
Antidepressant-induced hypomania
Hypersomnia
Retarded phenomenology
Psychotic depression
Postpartum episode

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Mean age of onset of mania following depressive episode

A

32 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Risk of suicide in patients with mood disorders compared to the general population

A

14 times greater

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

How long does an untreated depressive episode last for?

A

6-13 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

How long does a treated episode of depression last for?

A

3 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What happens to depressive episodes as the course of the disorder progresses?

A

More frequent episodes that last longer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Median episode length of depression?

A

12 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

How many patients with depression only had one episode and no future episodes

A

50%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

How many patients with depression will experience a recurrence in 5 years?

A

50%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

What is the risk of a patient with 2 major depressive episodes having a third?

A

70%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

What did Paykel et al show re relapses of depression?

A

Risk of relapse recurrence is higher in patients with residual symptoms (75% in 15 months) compared with those in full remission (25% in 15 months)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Over a lifetime, how many episodes do bipolar patients have compared to patients with depression?

A

Twice as many

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

What is defined as a partial response to treatment for depression?

A

26-49% decrease in symptom severity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

What is remission for depression?

A

When no scale can detect meaningful measure of depression (e.g. HAMD<7) and continue to do so after the natural period of a treated depressive episode (>3m)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

What is recovery in depression?

A

No scale can detect meaningful measure of depression after natural period of untreated depressive episode (>6m)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

What is a relapse of depression?

A

Any repeat of a depressive episode before recovery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

What is a recurrence of depression?

A

Repeat of a depressive episode after recovery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Good prognostic indicators for depression

A

Mild episodes
Absence of psychotic sx
Short hospital stay
Hx of sold friendships during adolescence
Stable family functioning
Sound social functioning for 5 years prior to illness
Absence of comorbid psychiatric disorder
No more than one previous hospitalization for depression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Relapse indicators for depression

A

Persistent dysthmia
Comorbid conditions - both psychiatric and medical
Female
Longer episodes of illness before seeking treatment
3 or more episodes of depression prior to treatment
Never marrying
Remission status at 3 months - partial remission predicts recurrence
Previous episode in past year
Severity of episode
Long previous episodes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

What is necessary re depression in primary care?

A

Screening high risk groups

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

What do you treat first if someone presents with both anxiety and depression?

A

Depression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

What needs to be done before depression can first be treated?

A

Severity must be classified

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

When is watchful waiting an agreeable strategy for depression?

A

For mild depression; must be reviewed in 2 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

Antidepressants for mild depression?

A

Poor risk-benefit ratio

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

Best advice for mild depression?

A

CBT-based guided self-help

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

Best advice for mild/moderate depression?

A

CBT
Counselling
Problem-solving therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

Which antidepressants are first line for depression?

A

SSRIs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

Best treatment for severe depression?

A

Combination of antidepressants and CBT - more cost-effective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

How long should antidepressants be continued in those with moderate or severe depression?

A

For at least 6 months after remission

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

Which patients must continue antidepressants for 2 years?

A

Patients with >2 episodes in recent past or residual impairment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

Treatment for atypical depression?

A

SSRI first line
Referral to specialist second line

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

What may specialists consider for women presenting with atypical depression?

A

Phenelzine if no response to SSRIs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

How long should patients remain on Lithium augmentation of antidepressant if helpful?

A

At least 6 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

When should ECT be considered in depression?

A

If adequate trial of other treatments is ineffective and/or when condition is potentially life-threatening in severe depression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

Is ECT maintenance recommended in depression

A

No

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

How long should treatment be continued for a single episode of depression?

A

At least 6-9 months after resolution of sx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

What does the MHRA say about SSRIs?

A

Use lowest possible dose
Monitor closely in early stages for restlessness, agitation and suicidality - particularly in those <30 y/o
Doses should be tapered gradually on stopping

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

What is NNT for antidepressant response?

A

4-5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
62
Q

What is NNT for antidepressants for remission?

A

6-7

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
63
Q

What is NNT for elderly with depression on TCAs?

A

4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
64
Q

What is NNT for elderly with depression on SSRIs?

A

8

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
65
Q

What is NNT for elderly with depression on MAOIs?

A

3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
66
Q

NNT benefit and harm for Paroxetine in children?

A

NNT benefit 12
NNT harm 20

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
67
Q

NNT benefit of Sertraline in depression in kids?

A

10

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
68
Q

NNT benefit of Fluoxetine in Depression in kids?

A

5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
69
Q

Who conducted a meta-analysis of 47 trials including 4-8 weeks RCT of antidepressants?

A

Kirsch

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
70
Q

What did Kirsch’s meta-analysis include

A

47 trials including 4-8 weeks RCTs of Nefazadone, Venlafaxine, Fluoxetine and Paroxetine.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
71
Q

Weighted mean improvement in Kirsch’s meta-analysis between treatment and placebo?

A

9.6 points on Hamilton in drug group
7.8 in placebo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
72
Q

Did Kirsch’s meta-analysis show significance in findings for antidepressant treatment?

A

Statistical significance but not the three-point Hamilton criterion for NICE for clinical significance.
Magnitude of difference was a function of baseline of severity of depression.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
73
Q

What did Kirsch’s meta-analysis show re placebo effect?

A

It declined as severity increased

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
74
Q

What type of approach does NICE recommend for treating depression?

A

Stepped care model advocated by WHO in managing chronic illness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
75
Q

Who created the phases of depression treatment after one episode?

A

Hirschfeld 2001

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
76
Q

How long does acute phase of depression last?

A

3 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
77
Q

How long does continuation phase of depression last?

A

If relapse free, 6-12 months.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
78
Q

How long does maintenance phase of depression last?

A

Aims to prevent recurrences - depends on risk factors and probability of recurrence.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
79
Q

What was Geddes research?

A

Pooled analysis of data from 31 randomised trials of 4,410 patients taking antidepressants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
80
Q

What did Geddes research show?

A

Continued treatment with all classes of antidepressants reduced risk of relapse by 70% compared with treatment discontinuation after acute episode

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
81
Q

Average rate of relapse on placebo in Geddes research?

A

41%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
82
Q

Average rate of relapse on antidepressant in Geddes research?

A

18%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
83
Q

Treatment effect duration of antidepressants in Geddes research?

A

36 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
84
Q

What is STAR*D?

A

Sequenced treatment alternative for depression was a pragmatic RCT - 2/3 had comorbid physical disorder, 2/3 had co-morbird psychiatric diagnosis and 40% had onset of depression at <18 years of age - similar to the real world.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
85
Q

How many patients in the STAR*D study?

A

4041 patients at 25 sites in the USA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
86
Q

How did STAR*D study work?

A

4 steps of treatment.
Any patient who failed to meet remission criteria at each step was moved up to the next level.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
87
Q

What was Level 1 in the STAR*D study?

A

Citalopram for up to 12 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
88
Q

What was Level 2 in the STAR*D study?

A

If after 12 weeks patient failed remission, they were randomized as per their preference to switch to either Bupropion, Sertraline or Venlafaxine, to cognitive therapy or to augment citalopram with Bupropion or Buspirone or to combine citalopram with cognitive therapy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
89
Q

What was level 3 in the STAR*D study?

A

Participants who did not achieve remission after 12 weeks in level 2 were randomised to switch to mirtazapine, nortriptyline or augment level 2 treatment with lithium or thyroid medication.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
90
Q

What was level 4 in the STAR*D study?

A

Patients who did not achieve remission after 12 weeks in level 3 were switched to an MAOI, tranylcypromine or switch to a combination of venlafaxine XR and mirtazapine.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
91
Q

What is measurement-based care which was used in the STAR*D study?

A

Routine measurement of symptoms and side effects at each treatment visit with the use of a treatment manual-guided when and how to modify doses tailored to each individual.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
92
Q

What happened has patients went up the levels in the STAR*D study?

A

Remission rates dropped
Relapse rates increased

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
93
Q

Cumulative remission rate after all 4 steps in STAR*D study?

A

67%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
94
Q

Cumulative non-response rate in STAR*D study?

A

33%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
95
Q

How many patients became symptom free after 2 levels in the STAR*D study?

A

Half of participants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
96
Q

What was the difference between switching to a class outside of an SSRI and to an SSRI in the STAR*D study?

A

No statistical difference

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
97
Q

What were the findings at level 3 of the STAR*D study?

A

No statistical difference between the different antidepressants or augmentation with Lithium or T3.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
98
Q

What were the results at level 4 in the STAR*D study?

A

No difference between MAOI and Mirtazapine/Venlafaxine XR combination although degree of symptom relief was better with the latter.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
99
Q

Factors leading to immediate attrition in STAR*D study?

A

Younger age
Less education
Higher perceived MH functioning

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
100
Q

Factors leading to late attrition (within 12 weeks) in the STAR*D study?

A

Younger age
Less Education
African American

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
101
Q

Evidence of dose escalation for depression?

A

Dose escalation before 4 weeks of treatment appears to be ineffective.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
102
Q

What did STAR*D study show re difference between men and women?

A

Men have more suicidal ideation and are 2-4 times more likely to complete suicide. They have more psychomotor agitation and substance use.

Women report more suicidal attempts, have more sx of anxiety and atypical depression, earlier age of onset and longer episodes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
103
Q

Who is at risk of suicidal behaviours when started on antidepressants?

A

<25 years of age

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
104
Q

What did Hawton et al study in 2010?

A

Toxicity of antidepressants in OD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
105
Q

What did Hawton el al (2010)’s study show?

A

TCAs have greater toxicity in OD than Venlafaxine & Mirtazapine, both of which have greater toxicity than SSRIs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
106
Q

Which TCAs are more toxic in an OD?

A

Dosulepin
Doxepin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
107
Q

Which SSRIs are most toxic in an OD?

A

Citalopram

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
108
Q

What are the 5As which can result in apparent resistance to antidepressant treatment?

A

Alcoholism
Lack of adequate dosage
Lack of adherence
Axis 2 disorders (PD)
Alternative diagnosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
109
Q

Which combination of antidepressants can lead to a risk of serotonin syndrome?

A

SSRI-MAOIs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
110
Q

What is ‘Californian rocket fuel’?

A

Venlafaxine & Mirtazapine combination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
111
Q

How does the SSRI and TCA combination work?

A

SSRIs inhibit TCA metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
112
Q

Which combination of antidepressants is found to be most effective?

A

No single combination is found to be superior to others

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
113
Q

How does Agomelatine work?

A

5HT2C antagonist, Metaltonergic agonist.
GABA interneurons tonically inhibit noradrenergic circuits for locus coeruleus and dopaminergic circuits from ventral tegmentum projecting to prefrontal cortex.

5HT2C receptor stimulation drives these GABA interneurons. Thus, norepinephrine and dopamine circuits are inhibited by the normal tonic release of serotonin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
114
Q

What medication has been found which when combined with antidepressants can speed response and reduce drop-out?

A

Benzos - manages early anxiety/agitation and insomnia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
115
Q

How to reduce sexual SEs of antidepressants?

A

Switching antidepressant
Adding Sildenagil or Tadafinil for erectile dysfunction or Bupropion 150mg BD for sexual dysfunction in men
Adding bupropion or sildenafil in women

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
116
Q

How can fatigue be reduced as a SE of antideoressants?

A

Modafinil may improve fatigue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
117
Q

Evidence for St Johns Wort in depression?

A

No conclusively positive findings.
Folate has a significant effect only when combined with an antidepressant.
St Johns Wort can increase effects of SSRIs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
118
Q

How does Ketamine act as an antidepressant?

A

Blockage of glutamatergic NMDA receptors and relative upregulation of AMPA receptors.
May also act on mammalian target of rampamycin (mTOR) and BDNF to affect intracellular signalling.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
119
Q

Clinical evidence of Ketamine as an antidepressant?

A

Rapid improvements in mood and suicidal thinking in 70% of participants, although effects are temporary when single infusion is administered.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
120
Q

What other disorders can Ketamine be used for (in research)?

A

Bipolar - positive results

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
121
Q

Prevalence of Bipolar?

A

1.5%

122
Q

What is NCS-replication?

A

Part of the World Mental Health survey initiative

123
Q

Lifetime prevalence of bipolar in NCS-replication?

A

Bipolar 1 - 1%
Bipolar 2 - 1.1%

124
Q

Mean age of onset of BP 1 and 2?

A

1 - 18.2
2 - 20

125
Q

Which Bipolar disorder has greater severity and impairment?

A

2

126
Q

What did Angst et al (2003)’s study show re Bipolar?

A

20 year long prospective study showed patients with depression and clinically undiagnosed subsyndromal hypomania have similar risk factors, course and outcome compared to Bipolar 2

127
Q

Suicide rate of Bipolar?

A

15-18x higher than the general population.

128
Q

How many people with bipolar experience another MH disorder?

A

2/3

129
Q

What are the two dimensions of mood disorders?

A

Proportionality - from predominant depression to predominant mania
Severity - from normal emotional states to psychotic mood states

130
Q

Who described an extension to bipolar 1 & 2 classification?

A

Akiskal and Pinto in 1999

131
Q

What was Akiskal and Pinto (1999)’s extension to Bipolar 1 and 2 classification?

A

1: manic-depressive illness
1 1/2: depression with protracted hypomania
2: depression with spontaneous hypomanic episodes
2 1/2: depression superimposed on cyclothymic temperament
3: recurrent depression plus hypomania occurring solely in association with antidepressant or other somatotherapy
3 1/2: mood swings that persist beyond stimulant and/or alcohol abuse
4: depression superimposed on a hyperthymic temperament

132
Q

What does DSM V now include re bipolar?

A

Emphasis on changes in activity and energy as well as mood when making diagnosis of manic of hypomanic episodes

133
Q

In how many patients with bipolar is a prodrome seen?

A

Half

134
Q

How long is the prodrome for bipolar?

A

> 1 year

135
Q

Which sx were more common in patients with bipolar who had a prodrome period?

A

Attenuated positive sx
Increased energy/goal-directed activity
All in patients with later psychotic mania

136
Q

Who confirmed that there was a correlation between stressful life events and first manic admission?

A

Ambelas

137
Q

In which patients is there a correlation between stressful life events and first manic episode?

A

Younger patients
(thought that sleep reduction may be final common pathway to mania)

138
Q

How many patients with bipolar get misdiagnosed with depression?

A

40%

139
Q

Which diagnosis of bipolar is more stable?

A

1

140
Q

Median time to recover from mania with treatment?

A

4-5 weeks

141
Q

Course specifiers for bipolar in DSM?

A

Chronicity
Seasonality
Rapid cycling

142
Q

How many patients with bipolar display specific pattern of predominant polarity?

A

56%

143
Q

How many patients with bipolar may be classified as predominantly depressed?

A

60%

144
Q

How many patients with bipolar are classified as predominantly manic or hypomanic?

A

40%

145
Q

Which type of bipolar is predominantly of depressive polarity?

A

2

146
Q

Which polarity of bipolar is seen in younger age group?

A

Mania

147
Q

Which polarity of bipolar shows more seasonality?

A

Depressive

148
Q

Which polarity of bipolar has more suicide attempts?

A

Depressive

149
Q

Which polarity of bipolar responds better to antipsychotics?

A

Manic

150
Q

Suicide rate in bipolar?

A

10-19%
15x greater than the general population

151
Q

How many people with bipolar will attempt suicide?

A

1/4

152
Q

Risk of recurrence in people with bipolar?

A

50% in one year
>70% at 4 years
compared with other psychiatric disorders

153
Q

How often do people with Bipolar 2 suffer from mood sx?

A

54%

154
Q

How often do people with Bipolar 1 suffer from mood sx?

A

47%

155
Q

How many people with Bipolar 2 experience depressive sx?

A

93%

156
Q

How many people with Bipolar 1 suffer from depressive sx?

A

67%

157
Q

What did Perlis et al. find re bipolar?

A

Biggest predictor of relapse was residual sx
Majority of relapse were into depression

158
Q

Which type of patients with bipolar spent the highest proportion of time being ill?

A

Patients with a depressive index spent 65% of the time unwel

159
Q

What % of time did people with a manic index phase unwell?

A

30%

160
Q

What is the ‘final common pathway’ triggering mania and depression?

A

Sleep disruption

161
Q

What comorbidities are linked to relapse of Bipolar?

A

Substance use increases risk of manic relapse
Anxiety increases risk of depressive relapse

162
Q

What is ‘switch’ in bipolar?

A

Antidepressant-induced mania

163
Q

When does switch occur?

A

Soon after starting antidepressants

164
Q

Definition of switch

A

Anti-depressant induced mania within 2 months of treatment - Ghaemia

165
Q

What is mood destabilisation?

A

Antidepressants result in increased frequency of mood episodes over time that would have occurred in the national course

166
Q

Which antidepressants have low rates of acute manic switch?

A

New generation

167
Q

Which antidepressants can produce long-term mood destabilisation?

A

New generation

168
Q

Which study found that new generation antidepressants can cause long-term mood destabilisation?

A

STEP-BD trial - Ghaemia, 2008

169
Q

What % of bipolar patients have had anti-depressant induced mania/hypomania?

A

20-40%

170
Q

What % of patients on Lithium had mood switches and what % did not?

A

15% lithium
44% not on lithium

171
Q

Risk factors for anti-depressant induced switch?

A

Previous antidepressant-induced mania
FHx of bipolar
Exposure to multiple antidepressants
Initial illness beginning in adolescence or young adulthood

172
Q

Which medications can cause a switch from mania to depression?

A

Antipsychotics

173
Q

What does Bipolar have that depression does not?

A

Lesser anxiety
Fewer physical complaints
More withdrawal
More retardation
Hypersomnia
More atypical sx

174
Q

What type of depression is suggestive of bipolar?

A

Psychotic depression in early adulthood

175
Q

What is rapid cycling?

A

4 or more episodes in a year - both mania and depression

176
Q

What is ultra-rapid cycling?

A

4 or more episodes in a month

177
Q

What is ultra-ultra rapid or ultraradian cycling?

A

4 or more episodes in a week

178
Q

What % of rapid cyclers are women?

A

80%

179
Q

Age of onset of illness of rapid cyclers?

A

Earlier than non-rapid cyclers

180
Q

Features of patients with rapid cycling

A

More severe depression and mania
Lower global functioning
Earlier age of onset
Current hypothyroidism
Poor response to lithium

181
Q

What is secondary mania?

A

Due to organic brain damage - usually right hemisphere
More common in elderly

182
Q

Which medications are associated with mania?

A

L-Dopa
Steroids

183
Q

DSM criteria for hypomania

A

4 days

184
Q

Duration criteria for mania

A

7 days

185
Q

Treatment of new onset mania

A

Antipsychotics - rapid anti-manic effect

186
Q

Which medication should not be used first line for new onset mania?

A

Lamotrigine

187
Q

Recommendations if patient presents with new onset mania and is on an antidepressant?

A

Consider stopping antidepressant
Offer antipsychotic regardless of whether antidepressant is stopped

188
Q

Recommendation of benzos for mania?

A

Clonazepam/Lorazepam can be used for agitation and insomnia

189
Q

Research re benzos for bipolar

A

For bipolar 1 experiencing a manic episode, clonazepam may be as effective as lithium in improving manic sx at 1-4 weeks.

190
Q

First option for acute manic relapse in a known bipolar patient?

A

Increasing dose of mood stabiliser

191
Q

Treatment option for manic relapse in bipolar patient on lithium

A

Check serum lithium levels and consider establishing higher serum level if good compliance.

192
Q

2nd line treatment for manic relapse in bipolar patient on lithium

A

Consider adding haloperidol, olanzapine, quetiapine or risperidone

193
Q

In which patients with bipolar can antipsychotic augmentation be done?

A

Those on valproate

194
Q

When is ECT considered in mania?

A

Severely ill manic patients
Treatment-resistant mania
Those who prefer ECT
Severe mania during pregnancy

195
Q

Which psychiatric drug has a high association with low Na?

A

Carbamazapine
Oxcarbazepine

196
Q

First line treatment for depression in bipolar

A

Psychological intervention specific for bipolar depression or high-intensity psychological intervention

197
Q

Pharmacological treatment guidelines for depression in bipolar

A

If not on medication, fluoxetine combined with olanzapine or quetiapine on its own

198
Q

Second step for pharmacological treatment of depression in bipolar

A

Lamotrigine

199
Q

When does NICE recommend using long-term maintenance treatment for bipolar?

A

After manic episode involving significant risk and adverse consequences
Bipolar 1 with 2 or more acute episodes
Bipolar 2 with significant functional impairment or risk

200
Q

First line maintenance treatment for bipolar?

A

Lithium

201
Q

Which drug is associated with reduced risk of suicide in bipolar?

A

Lithium

202
Q

Lithium maintenance responders profile?

A

Euphoric mania
No rapid cycling
Full interepisode remission
No comorbidity
No psychotic features
Fewer lifetime episodes

203
Q

Other treatment options for maintenance of bipolar

A

Valproate
Olanzapine
Quetiapine
Carbamazapine
Lamotrigine

204
Q

Which medications prevent depressive relapses more than manic?

A

Lamotrigine

205
Q

Which medications prevent manic relapses more than depressive?

A

Valproate
Olanzapine

206
Q

How to manage mixed episodes of bipolar?

A

Treat as manic episodes
Avoid antidepressants
Best evidence is for valproate and atypical antipsychotics

207
Q

What to consider when treating rapid cycling?

A

Treat any hypothyroidism or substance misuse
Stop antidepressants
Consider suboptimal medication regime, lithium withdrawal and non-compliance

208
Q

Treatment of rapid cycling?

A

Lithium, valproate or Lamotrigine

209
Q

How long should maintenance treatment be continued for in bipolar?

A

2 years after episode
5 years if high-risk factors for relapse

210
Q

First line treatment for paediatric bipolar?

A

Atypical antipsychotic

211
Q

Research for adjunctive antidepressant use in bipolar?

A

24% of antidepressant achieved primary outcome
27% of placebo group achieved primary outcome

212
Q

Which study did research in adjunctive antidepressant use in bipolar?

A

STEP_BD

213
Q

Which antidepressant as a higher risk of precipitating a switch to mania?

A

TCAs

214
Q

What happens in antidepressant-associated chronic irritable dysphoria?

A

Occurs in bipolar patients who have received antidepressants for a long period of time.

215
Q

Sx of antidepressant–associated chronic irritable dysphoria?

A

Irritability
Mixed insomnia
Dysphoria

216
Q

Which anti-epileptic can cause psychosis?

A

Vigabatrin

217
Q

Bauer et al.’s definition of a mood stabiliser?

A

Efficacy in:
treatment of acute manic sx
treatment of acute depressive sx
prevention of manic sx
prevention of depressive sx

218
Q

According to Bauer et al., which medications can be classified as mood stabilisers?

A

Lithium

219
Q

Suicide risk of bipolar patients admitted to hospital long-term?

A

10%

220
Q

Components of CBT for bipolar?

A

Psych-education
Self-monitoring
Self-regulation: action plans and modification of behaviours
Increased compliance

221
Q

Difference in criteria for bipolar in children as per NICE?

A

Mania must be present
Euphoria must be present most days, most of the time (7 days)
Irritability is not a core diagnostic criterion.

222
Q

Incidence of schizophrenia

A

16-42 per 100,000

223
Q

What did McGrath et al. show?

A

Five-fold difference in incidence rates of schizophrenia across various sites

224
Q

Risk of schizophrenia in urban sites vs rural?

A

Two-fold in urban

225
Q

Incidence of schizophrenia in migrants?

A

3-5 times more common than the native population

226
Q

Which births increase risk of schizophrenia?

A

Winter/spring birth

227
Q

Male:female ratio of schizophrenia?

A

1.4:1

228
Q

Median prevalence of schizophrenia?

A

4.6/1000 - point prevalence

229
Q

Period prevalence of schizophrenia

A

3.3/1000

230
Q

Lifetime prevalence for schizophrenia

A

4/1000

231
Q

Lifetime morbid risk of schizophrenia

A

7.2/1000

232
Q

Which groups have higher rates of schizophrenia?

A

Migrants
Homeless

233
Q

Which countries have a lower prevalence of schizophrenia?

A

Developing countries

234
Q

Catatonia in developing vs developed countries

A

10% in developing
1% in developed

235
Q

Hebephrenia in developing vs developed countries

A

13% in developed
4% in developed

236
Q

Which study looked at schizophrenia in BME communites?

A

AESOP study

237
Q

What did the AESOP study find?

A

All psychoses are more common in BME groups compared to white population in Bristol, SE london and Nottingham

238
Q

What did ONS 2000 Psychiatric comorbidity survey of households find?

A

5.5% endorsed at least one psychosis item
4.2% endorsed hallucination item: of this, 4.2% said they heard/saw something others could’nt, 0.7% reported hearing voices

239
Q

What is the genetic assumption re schizophrenia?

A

Individuals at enhanced genetic risk of schizophrenia i.e. FHx of schizophrenia inherit a state of vulnerability characterised by transient and partial psychosis-like sx

240
Q

Who did a study into genetic risk of schizophrenia?

A

Johnstone et al. 2005

241
Q

What did Johnstone et al. 2005’s study find re schizophrenia?

A

10% risk present in those with high risk FHx increases to nearly 50% in subgroup of those who have a high score on schizotypal cognition and social withdrawal.

242
Q

What did Johnstone et al. 2005’s study show re discriminating factors for high risk development of schizophrenia?

A

Measures of episodic memory may be significantly discriminating between those with high risk who develop schizophrenia frm those who do not; suggestive of temporal lobe dysfunction.

243
Q

What did the Australian PACE clinic sample show?

A

20 of 49 high-risk subjects (40.8%) developed a psychotic disorder within 12 months.

244
Q

What did Australian PACE clinic sample show were risk factors of developing psychosis?

A

Long duration of prodrome
Poor functioning at intake
Low-grade psychotic sx
Depression
Disorganization

245
Q

What did a German study show re schizophrenia?

A

Using Bonn Basic Sx criteria, high conversion rate was seen in help-seeking individuals in long follow-up period of 10 years.
They found 5 of the sx clusters of the Bonn scale were a significant predictive discriminator.

246
Q

Which 5 sx clusters of the Bonn scale have been found to be significant discriminators of psychosis in the future?

A

Presence of thought, language, perception and motor distrubances

247
Q

What did the North American Prodrome Longitudinal study (NAPLS) find?

A

High risk UHR criteria predict early transition to psychosis.

248
Q

Incidence of delusional disorders

A

0.7-1.3 per 100,000

249
Q

Prevalence of delusional disorders

A

24-30 per 100,000

250
Q

Proportion of people with delusional disorder admitted to hospital

A

1-3%

251
Q

Mean age of onset of delusional disorder

A

39 y/o

252
Q

Sex ratio of delusional disorder

A

1.18:1 - M:F

253
Q

What was the structure of the Iowa study show re outcomes for schizophrenia?

A

186 people with schizophrenia were followed-up for 35 years.

254
Q

What did the Iowa study show re outcomes for schizophrenia?

A

46% of people improved or recovered.

255
Q

What was the structure of the Bonn Hospital Study in Germany?

A

502 people with schizophrenia were followed up for 22.4 years.

256
Q

Results of Bonn Hospital Study in Germany?

A

22% had complete remission of sx
43% had non-characteristic types of remission (non-psychotic)
35% experienced characteristic schizophrenia residual sx.

257
Q

Structure of Chestnut Lodge study

A

446 patients with schizophrenia were followed-up for 15 years

258
Q

What did the Chestnut Lodge study show re schizophrenia?

A

36% recovered or functioned adequately.

259
Q

What did the Vermont longitudinal study show re outcomes of schizophrenia?

A

68% of patients who underwent a rehab programme had good functioning as per the GAF scale.

260
Q

What was the International study of Schizophrenia (ISoS 1997)

A

Follow-up analysis of two major WHO incidence cohorts from 9 countries.

261
Q

Results from ISoS 1997 study

A

52% of patients in developing countries were assessed to be in the ‘best’ outcome category (single episode followed by partial or full recovery) compared with 39% in developed countries

262
Q

What did ISoS 1997 study show re follow-up of patients with schizophrenia?

A

At 5 years, 73% of those from developing countries were in the best outcome group compared with 52% in developed countries.

263
Q

What did the DOSMeD study show re schizophrenia?

A

Highest rates of recover occurred in the developing world.

264
Q

What should we divide risk factors into?

A

Risk indicators
Risk modifiers

265
Q

What are risk indicators?

A

Increased risk but not causative

266
Q

What are risk modifiers?

A

Associated with causation

267
Q

Risk of schizophrenia if both parents have schizophrenia

A

40-50%

268
Q

Single nucleotide polymorphisms (SNPs) linked to schizophrenia

A

12p13.33
12q24.11
1q42.2
11q23.2
2q33-34
5q33.2
16p13
7q21
1p21
8p12
17p13
18q21
2q32

269
Q

Copy Number Variations (CNVs) linked to schizophrenia

A

2p16.3 deletion
7q36.3 duplication
Hemi deletion of 22q11

270
Q

Gene of 12p13.33

A

CACNA1C (L-type calcium channel)

271
Q

What is CACNA1C important for?

A

Neuronal function

272
Q

What do mutations of CACNA1C cause?

A

Timothy Syndrome
Brugada Syndrom

273
Q

Gene of 12q24.11?

A

D-amino acid oxidase

274
Q

What is D-amino acid oxidase important for?

A

Degrades d-serine (NMDA co-agonist)

275
Q

Gene of 1q42.2?

A

DISC-1

276
Q

What is DISC-1 seen in?

A

Scottish family with 1:11 translocation
Disrupted in schizophrenia

277
Q

Gene of 11q23.2?

A

Dopamine D2 receptor

278
Q

Importance of 11q23.2?

A

Target for antipsychotic action

279
Q

Gene for 2q33-34?

A

Receptor tyrosine kinase erbB4

280
Q

Importance of 2q33-34?

A

Neuregulin 1 receptor

281
Q

Gene for 5q22.3?

A

AMPA receptor subunit 1

282
Q

Importance of 5q33.2?

A

Affects synaptic plasticity

283
Q

Gene for 16p13?

A

NMDA receptor subunit 2A

284
Q

Importance of 16p13?

A

Influences channel conductance and synaptic localisation

285
Q

Gene of 7q21?

A

Metabotropic glutamate receptor 3

286
Q

Importance of 7q21?

A

Inhibitory autoreceptor

287
Q

Gene of 1p21?

A

Micro RNA 137

288
Q

Importance of 1p21?

A

Regulates transcription

289
Q

Gene of 8p12?

A

Neuregulin 1

290
Q

Importance of 8p12

A

Growth factor

291
Q

Gene of 17p13?

A

Serine racemase

292
Q

Importance of serine racemase?

A

Synthesizes d-serine from l-serine

293
Q

Gene of 18q21?

A

Transcription factor 4

294
Q

Importance of transcription factor 4?

A

Deletion causes Pitt-Hopkins syndrome

295
Q

Gene of 2q32?

A

Zinc finger 804A

296
Q

Importance of zinc finger 804A?

A

Affects gene regulation especially in cortical pyramidal neurons

297
Q

Gene of 2p16.3 deletion?

A

Neurexin 1

298
Q

Importance of Neurexin 1?

A

Involved in synaptic structure

299
Q

Gene at 7q36.3 duplication?

A

Vasoactive intestinal peptide receptor 2

300
Q

Importance of VIP receptor 2?

A

Regulates synaptic transmission in hippocampus and development of neural progenitor cells in dentate gyrus

301
Q

Gene at 22q11

A

COMT coding genes

302
Q

What does hemi deletion of 22q11 cause?

A

Velocardiofacial syndrome

MRCPsych Part B (64 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions